FAPL-PI3Ki1

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameFAPL-PI3Ki1
Drug Alias NameFAPL-PI-3-Ki-1FAPL-PI3Ki1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast activation protein alpha antagonists
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPurdue University
China Registration ClassN/A

Develop Information

Active CompaniesPurdue University
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A